SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following segments: Walmart U.S., Walmart International, and Sam's Club U.S. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club U.S. segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is currently facing significant selling pressure as investors react to a rare miss in same-store sales growth and a soft forward guidance, despite reporting a revenue and earnings beat. The community remains deeply divided, with many debating whether the drop is an overreaction offering a compelling long-term entry point or a broader sign of impending stress on the American consumer.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is surging following a strong quarterly earnings report that significantly beat analyst expectations for revenue and profit, driven by record trading volumes and increased customer assets. While the community is actively debating the stock's long-term valuation compared to brokerage peers, traders are closely watching for a potential short squeeze as momentum builds around its recent double-beat performance.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is experiencing significant market attention and a positive price trend as the investment community reacts to clinical advancements in the personalized cancer immunotherapy space. Investors are actively discussing the potential for a short squeeze, anticipating upcoming clinical data readouts, and speculating on the prospect of a buyout as the company continues to scale its commercial operations.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending as market participants react to a high-profile industry meeting at the White House, fueling speculative discussions about potential regulatory clarity and institutional adoption. The community is actively debating the sustainability of this price action, with bulls pointing to heavy whale accumulation and short liquidations while bears warn of potential volatility and profit-taking risks.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market attention following its strategic $1.5 billion acquisition of Personalis, an expansion that has sparked intense debate over dilution risks versus the long-term value of integrating cancer-monitoring technology into its precision medicine platform. Community sentiment remains polarized, with many investors actively discussing the stock's high short interest and volatility, while others view the pullback as a buying opportunity given the company's expanding AI-driven healthcare ecosystem.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors capitalize on a significant Bitcoin rally driven by federal bond buyback announcements and optimism surrounding upcoming crypto policy discussions. The community is actively debating the stock's role as a leveraged crypto proxy, with bulls pointing to the potential for a short squeeze while bears remain focused on long-term dilution concerns.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group Inc. is trending as investors digest a new bullish initiation from Compass Point with a $44 price target, while active discussions center on the company's significant short interest and the anticipation surrounding its upcoming second-quarter financial results. Community members are closely monitoring for an official earnings date announcement, with many expressing confidence that the combination of strong institutional backing and growth in its AI-focused commercial pipeline could catalyze a major revaluation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences (SLS) is seeing increased investor attention as positive clinical updates in the broader cancer vaccine sector fuel speculation about the potential re-rating of its own immunotherapy platform. Community discussion is currently fixated on the upcoming Phase 3 trial readout, with active debates centered on how trial design and recent industry validation could impact buyout prospects and long-term valuation.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending as investors digest a series of analyst target price increases alongside significant volatility that has sparked intense debate over the company's valuation versus its role in an increasingly AI-focused cybersecurity landscape. While bulls highlight resilient enterprise spending and the company's strategic importance, community sentiment remains sharply divided between those viewing the stock as a long-term leader and others who expect further technical pullbacks.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is currently seeing heightened volatility and intense retail debate as the community reacts to a recent portfolio shift by major investors and ongoing concerns about sector-wide competition from prediction markets. Investors remain deeply divided, weighing the stock's long-term potential during the upcoming football season against broader concerns about revenue growth, promotional spending, and the company's ability to maintain its market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Pure Bioscience Inc. Is that bullish or bearish? $PURE #RsiOverbought #PINK

dlvr.it

Pure Bioscience

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Pure Bioscience Inc. Is that bullish or bearish? 

Penke Investing

@PenkeTrading everything, and the world with it, depends on your trading style. Liking the setup myself. Prolly gonna  wait and watch today. If the setup holds I’ll get in soon.

StockTwits for iOS

 everything, and the world with it, depends on your trading style. Liking the setup myself. Prolly gonna  wait and watch today. If the setup holds I’ll get in soon.